Borderline personality and substance use in women

American Journal on Addictions

Volumn 15, Issue 2, 2006, Pages 131-137

  Feske, Ulrike ^a   Tarter, Ralph E ^b   Kirisci, Levent ^b   Pilkonis, Paul A ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE; DIAMORPHINE;

ADULT; ALCOHOL ABUSE; ALCOHOL CONSUMPTION; ARTICLE; BORDERLINE STATE; COCAINE DEPENDENCE; CONTROLLED STUDY; DRUG USE; FEMALE; HEROIN DEPENDENCE; HISTRIONIC PERSONALITY DISORDER; HUMAN; LIFESPAN; MAJOR CLINICAL STUDY; MULTIPLE DRUG ABUSE; PREDICTION; PSYCHOPATHY; STATISTICAL ANALYSIS; SUBSTANCE ABUSE;

ADULT; ALCOHOLISM; ANTISOCIAL PERSONALITY DISORDER; ANXIETY DISORDERS; BORDERLINE PERSONALITY DISORDER; COCAINE-RELATED DISORDERS; COMORBIDITY; DEPRESSIVE DISORDER; DIAGNOSIS, DUAL (PSYCHIATRY); FEMALE; HEROIN DEPENDENCE; HISTRIONIC PERSONALITY DISORDER; HUMANS; LONGITUDINAL STUDIES; MALE; MARIJUANA ABUSE; MIDDLE AGED; PERSONALITY ASSESSMENT; PROGNOSIS; STATISTICS; STATISTICS AS TOPIC; SUBSTANCE-RELATED DISORDERS;

EID: 33645788372     PISSN: 10550496     EISSN: 15210391     Source Type: Journal    
DOI: 10.1080/10550490500528357     Document Type: Article

References (66)

1. Brooner RK, King VL, Kidorf M, et al. Psychiatric and substance use comorbidity among treatment-seeking opioid abusers. Arch Gen Psychiatry. 1997;54:71-80.
2. Darke S, Williamson A, Ross J, Teesson M, Lynskey M. Borderline personality disorder, antisocial personality disorder and risk taking among heroin users: findings from the Australian Treatment Outcome Study (ATOS). Drug Alcohol Depend. 2004;74:77-83.
3. Grilo CM, McGlashan TH, Quinlan DM, Walker ML, Greenfeld D, Edell WS. Frequency of personality disorders in two age cohorts of psychiatric patients. Am J Psychiatry. 1998;155:140-142.
4. Morgenstern J, Langenbucher J, Labouvie E, Miller KJ. The comorbidity of alcoholism and personality disorders in a clinical population: prevalence rates and relation to alcohol typology variables. J Abnorm Psychol. 1997;106:74-84.
5. Skodol AE, Oldham JM, Gallaher PE. Axis II comorbidity of substance use disorders among patients referred for treatment of personality disorders. Am J Psychiatry. 1999;156:733-738.
6. Zanarini MC, Frankenburg FR, Dubo ED, et al. Axis I comorbidity of borderline personality disorder. Am J Psychiatry. 1998;155:1733-1739.
7. Trull TJ, Sher KJ, Minks-Brown C, Durbin J, Burr R. Borderline personality disorder and substance use disorders: a review and integration. Clin Psychol Rev. 2000;20:235-253.
8. Ross S, Dermatis H, Levounis P, Galanter M. A comparison between dually diagnosed inpatients with and without Axis II comorbidity and the relationship to treatment outcome. Am J Drug Alcohol Abuse. 2003;29:263-279.
9. Rounsaville BJ, Kranzler HR, Ball S, Tennen H, Poling J, Triffleman E. Personality disorders in substance abusers: relation to substance use. J Nerv Ment Dis. 1998;186:87-95.
10. Gupta B, Trzepacz PT. Serious overdoses admitted to a general hospital: comparison with non-overdose self-injuries and medically ill patients with suicidal ideation. Gen Hosp Psychiatry. 1997;19:209-215.
11. Kruedelbach N, McGormick RA, Schulz SC, Grueneich R. Impulsivity, coping style, and triggers for craving in substance abusers with borderline personality disorder. J Personal Disord. 1993;7:214-222.
12. Links PS, Heslegrave RJ, Mitton JE, van Reekum R, Patrick J. Borderline personality disorder and substance abuse: consequences of comorbidity. Can J Psychiatry. 1995;40:9-14.
13. Miller FT, Abrams T, Dulit R, Fyer M. Substance abuse in borderline personality disorder. Am J Drug Alcohol Abuse. 1993;19:491-497.
14. Nace EP, Davis CW. Treatment outcome in substance-abusing patients with a personality disorder. Am J Addict. 1993;2:26-33.
15. Nace EP, Saxon JJ, Shore N. Borderline personality and alcoholism treatment: a one-year follow-up study. J Stud Alcohol. 1986;47:196-200.
16. Schaar I, Öjehagen A. Severely mentally ill substance abusers: an eighteen-month follow-up study. Soc Psychiatry Psychiatr Epidemiol. 2001;36:70-78.
17. van den Bosch LMC, Verheul R, van den Brink W. Substance abuse in borderline personality disorder: clinical and etiological correlates. J Personal Disord. 2001;15:416-424.
18. Yen S, Shea MT, Pagano M, et al. Axis I and Axis II disorders as predictors of prospective suicide attempts: findings from the Collaborative Longitudinal Personality Disorders Study. J Abnorm Psychol. 2003;112:375-381.
19. Beautrais AL, Joyce PR, Mulder RT, Fergusson DM, Deavoll BJ, Nightingale SK. Prevalence and comorbidity of mental disorders in persons making serious suicide attempts: a case-control study. Am J Psychiatry. 1996;153:1009-1014.
20. Brooner RK, Bigelow GE, Strain E, Schmidt CW. Intravenous drug abusers with antisocial personality disorder: increased HIV risk behavior. Drug Alcohol Depend. 1990;26:39-44.
21. Brooner RK, Greenfield L, Schmidt CW, Bigelow GE. Antisocial personality disorder and HIV infection in drug abusers. Am J Psychiatry. 1993;150:53-58.
22. Darke S, Hall W, Swift W. Prevalence, symptoms and correlates of antisocial personality disorder among methadone maintenance clients. Drug Alcohol Depend. 1994;34:253-257.
23. Darke S, Kaye S, Finlay-Jones R. Antisocial personality disorder, psychopathy and injection drug use. Drug Alcohol Depend. 1998;52:63-69.
24. Gill K, Nolimal D, Cowdry TJ. Antisocial personality disorder, HIV risk behaviour and retention in methadone maintenance therapy. Drug Alcohol Depend. 1992;30:247-252.
25. Hatzitaskos P, Soldatos CR, Kokkevi A, Stefanis CN. Substance abuse patterns and their association with psychopathology and type of hostility in male patients with borderline and antisocial personality disorder. Compr Psychiatry. 1999;40:278-282.
26. Rutherford MJ, Cacciola JS, Alterman AI. Relationships of personality disorders with problem severity in methadone patients. Drug Alcohol Depend. 1994;35:69-76.
27. Woody GE, McLellan AT, Luborsky L, O'Brien CP. Sociopathy and psychotherapy outcome. Arch Gen Psychiatry. 1985;42:1081-1086.
28. Skodol AE, Bender DS. Why are women diagnosed borderline more than men? Psychiatr Q. 2003;74:349-360.
29. Zanarini MC, Gunderson JG. Differential diagnosis of antisocial and borderline personality disorders. In: Stoff DM, Breiling J, Maser JD, eds. Handbook of Antisocial Behavior. New York, NY: Wiley & Sons; 1997:83-91.
30. Paris J. Antisocial and borderline personality disorders: two separate diagnoses or two aspects of the same psychopathology? Compr Psychiatry. 1997;38:237-242.
31. Gerstley LJ, Alterman AI, McLellan AT, Woody GE. Antisocial personality disorder in patients with substance abuse disorders: a problematic diagnosis? Am J Psychiatry. 1990;147:173-178.
32. Hare RD. A research scale for the assessment of psychopathy in criminal populations. Personality (and) Individual Differences. 1980;1:111-119.
33. Pilkonis PA, Heape CL, Proietti JM, Clark SW, McDavid JD, Pitts TE. The reliability and validity of two structured diagnostic interviews for personality disorders. Arch Gen Psychiatry. 1995;52: 1025-1033.
34. Kim Y, Pilkonis PA. Selecting the most informative items in the IIP scales for personality disorders: an application of item response theory. J Personal Disord. 1999;13:157-174.
35. Pilkonis PA, Kim Y, Proietti JM, Barkham M. Scales for personality disorders developed from the Inventory of Interpersonal Problems. J Personal Disord. 1996;10:355-369.
36. American Psychiatric Association. The Diagnostic and Statistical Manual of Mental Disorders. Fourth edition, rev. Washington, DC: American Psychiatric Association; 1994.
37. American Psychiatric Association. The Diagnostic and Statistical Manual of Mental Disorders. Third edition, rev. Washington, DC: American Psychiatric Association; 1987.
38. Pilkonis PA, Heape CL, Ruddy J, Serrao P. Validity in the diagnosis of personality disorders: the use of the LEAD standard. Psychol Assess. 1991;3:46-54.
39. Spitzer RL, Williams JBW, Gibbon M, First MB. Structured Clinical Interview for DSM-III-R: Patient Edition (with Psychotic Screen). New York, NY: Biometrics Research Department, New York State Psychiatric Institute; 1989.
40. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV: Patient Edition (with Psychotic Screen). New York, NY: Biometrics Research Department, New York State Psychiatric Institute; 1995.
41. Hamilton MA. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56-62.
42. Hamilton MA. The assessment of anxiety states by rating. Br J Med Psychol. 1959;32:50-55.
43. Derogatis LR, Melisaratos N. The Brief Symptom Inventory: an introductory report. Psychol Med. 1983;13:595-605.
44. Heape CL, Pilkonis PA, Lambert J, Proietti JM. Interpersonal Relations Assessment. Pittsburgh, PA: University of Pittsburgh, Department of Psychiatry; 1989.
45. Horowitz LM, Rosenberg SE, Baer BA, Ureño G, Villaseñor VS. Inventory of interpersonal problems: psychometric properties and clinical applications. J Consult Clin Psychol. 1988;56:885-892.
46. Costa PT, McCrae RR. The NEO Personality Inventory - Manual. Odessa, Fla.: Psychological Assessment Resources; 1985.
47. Loranger AW. Personality Disorders Examination (PDE) Manual. Yonkers, NY: DV Communications; 1988.
48. Pfohl B, Blum N, Zimmerman M, Stangl D. Structured Interview for DSM-IV Personality Disorders (SIDP-IV). Iowa City, Ia.: University of Iowa, Department of Psychiatry; 1995.
49. First MB, Gibbon M, Spitzer RL, Williams JBW, Benjamin LS. Structured Clinical Interview for DSM-IV Axis II Personality Disorders. Washington, DC: American Psychiatric Press; 1997.
50. Hill J, Harrington R, Fudge H, Rutter M, Pickles A. Adult Personality Functioning Assessment (APFA). Br J Psychiatry. 1989; 155:24-35.
51. Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol. 1986;51:1173-1182.
52. MacKinnon DP, Lokwood CM, Hoffman JM, West SG, Sheets V. A comparison of methods to test mediation and other intervening variable effects. Psychol Methods. 2002;7:83-104.
53. Freedman LS, Schatzkin A. Sample size for studying intermediate endpoints within intervention trials of observational studies. Am J Epidemiol. 1992;136:1148-1159.
54. Clogg CC, Petkova E, Shihadeh ES. Statistical methods for analyzing collapsibility in regression models. J Educ Stat. 1992;17: 51-74.
55. DeJong CAJ, van den Brink W, Harteveld FM, van der Wielen EGM. Personality disorder in alcoholics and drug addicts. Compr Psychiatry. 1993;34:87-94.
56. Nace EP, Davis CW, Gaspari JP. Axis II comorbidity in substance abusers. Am J Psychiatry. 1991;148:118-120.
57. Weiss RD, Mirin SM, Griffin ML, Gunderson JG, Hufford C. Personality disorders in cocaine dependence. Compr Psychiatry. 1993;34:145-149.
58. Grant BF, Stinson FS, Dawson DA, Chou SP, Ruan JW, Pickering RP. Co-occurrence of twelve-month alcohol and drug use disorders and personality disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry. 2004;61:361-368.
59. Paris J. Childhood precursors of borderline personality. Psychiatr Clin N Am. 2000;23:77-88.
60. Zanarini MC, Frankenburg FR. Pathways to the development of borderline personality. J Personal Disord. 1997;11:93-104.
61. Monarch ES, Saykin AJ, Flashman LA. Neuropsychological impairment in borderline personality disorder. Psychiatr Clin N Am. 2004;27:67-82.
62. Tarter RE, Kirisci L, Mezzich A, et al. Neurobehavioral disinhibition in childhood predicts early age onset of substance use disorder. Am J Psychiatry. 2003;116:1078-1085.
63. Zanarini MC, Frankenburg FR, DeLuca CJ, Hennen J, Khera GS, Gunderson JG. The pain of being borderline: dysphoric states specific to borderline personality disorder. Harvard Rev Psychiatry. 1998;6:201-207.
64. Zanarini MC, Frankenburg FR, Hennen J, Reich DB, Silk KR. Axis I comorbidity in patients with borderline personality disorder: a six-year follow-up and prediction of time to remission. Am J Psychiatry. 2004;161:2108-2114.
65. National Academy of Sciences. The Hidden Epidemic: Confronting Sexually Transmitted Diseases. Washington, DC: National Academy Press; 1997.
66. Linehan MM. Cognitive-Behavioral Treatment of Borderline Personality Disorder. New York: Guilford Press; 1993.